Horn Howard

Chief Financial Officer | CFO

2 companies

Excellent

Trades Analyzed

12M Win Rate

100.0%

Avg 3M Return

+15.2%

Avg 12M Return

+44.2%

Horn Howard is a CFO at Vir Biotechnology, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $4.4M based on current market prices.

Holdings by Company

VIRFeb 23, 2023

Current Shares230.7K

Value$2.10M

Net Activity-107,065

Bought: 0Sold: 107.1K

RAREFeb 2, 2026

Current Shares88.9K

Value$2.32M

Net Activity-26,484

Bought: 0Sold: 26.5K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 2, 2026	RARE Ultragenyx Pharmaceutical Inc.	Chief Financial Officer	Sell	3,061	$23.56	$72,117.16	-3.3%	+0.0%	-
Jan 2, 2026	RARE Ultragenyx Pharmaceutical Inc.	Chief Financial Officer	Sell	3,150	$22.84	$71,946.00	-3.3%	-4.9%	-
Dec 10, 2025	RARE Ultragenyx Pharmaceutical Inc.	Chief Financial Officer	Sell	3,081	$36.38	$112,086.78	-3.1%	-36.5%	-
Oct 13, 2025	RARE Ultragenyx Pharmaceutical Inc.	Chief Financial Officer	Sell	7,942	$31.51	$250,252.42	-7.5%	-23.9%	-
Mar 6, 2025	RARE Ultragenyx Pharmaceutical Inc.	Chief Financial Officer	Sell	1,785	$40.40	$72,114.00	-1.7%	-8.5%	-46.9%
Oct 10, 2024	RARE Ultragenyx Pharmaceutical Inc.	Chief Financial Officer	Sell	7,465	$52.76	$393,853.40	-7.5%	-19.0%	-41.6%
Feb 23, 2023	VIR Vir Biotechnology, Inc.	CFO	Sell	2,248	$25.97	$58,387.30	-1.0%	+1.1%	-55.3%
Feb 17, 2023	VIR Vir Biotechnology, Inc.	CFO	Sell	2,424	$25.29	$61,298.11	-1.0%	-3.3%	-60.2%
Feb 17, 2022	VIR Vir Biotechnology, Inc.	CFO	Sell	2,393	$31.93	$76,410.64	-1.2%	-26.6%	-16.8%
Jul 13, 2020	VIR Vir Biotechnology, Inc.	CFO	Sell	30,000	$50.06	$1,501,731.00	-14.4%	-	-